https://www.selleckchem.com/pr....oducts/gsk-j4-hcl.ht
Based on the average duration of dialysis, annual dialysis costs were determined, discounting 2020 US dollars at an inflation rate of 4%. Following the acute and chronic eGFR slopes, the projected time to dialysis was 22.85years for canagliflozin and 9.90years for placebo. Based on 95% confidence intervals from CREDENCE, the model-estimated difference in time to dialysis was 9.27-17.48years. With a mean baseline participant age of 63years, the delay in dialysis with canagliflozin would be associated with a reduction in dialysis costs
Like
Comment
Share
